🇺🇸 Androgel (Testosterone Gel) in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Confusional State — 2 reports (16.67%)
  2. Fatigue — 2 reports (16.67%)
  3. Agitation — 1 report (8.33%)
  4. Asthenia — 1 report (8.33%)
  5. Axillary Vein Thrombosis — 1 report (8.33%)
  6. Basal Cell Carcinoma — 1 report (8.33%)
  7. Blood Testosterone Decreased — 1 report (8.33%)
  8. Convulsion — 1 report (8.33%)
  9. Cough — 1 report (8.33%)
  10. Disorientation — 1 report (8.33%)

Source database →

Other Endocrinology approved in United States

Frequently asked questions

Is Androgel (Testosterone Gel) approved in United States?

Androgel (Testosterone Gel) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Androgel (Testosterone Gel) in United States?

National Institute on Aging (NIA) is the originator. The local marketing authorisation holder may differ — check the official source linked above.